VanEck Pharmaceutical ETF
140 hedge funds and large institutions have $515M invested in VanEck Pharmaceutical ETF in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $544M → $515M (-$28.6M)
71% less call options, than puts
Call options by funds: $1.25M | Put options by funds: $4.37M
Holders
140
Holding in Top 10
1
Calls
$1.25M
Puts
$4.37M
Top Buyers
| 1 | +$16.8M | |
| 2 | +$16.7M | |
| 3 | +$15.6M | |
| 4 |
Two Sigma Investments
New York
|
+$12.5M |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$11.4M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$13.8M | |
| 3 | -$8.82M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$7.06M |
| 5 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$3.77M |